This brand name is authorized in Nigeria.
The drug SUGAM contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
804826J2HU - AMOXICILLIN
|
|
Amoxicillin is a semisynthetic penicillin (beta-lactam antibiotic) that inhibits one or more enzymes (often referred to as penicillin-binding proteins, PBPs) in the biosynthetic pathway of bactericidal peptidoglycan, which is an integral structural component of the bacterial cell wall. Inhibition of peptidoglycan synthesis leads to weakening of the cell wall, which is usually followed by cell lysis and death. |
|
2
|
UNII
Q42OMW3AT8 - CLAVULANATE POTASSIUM
|
|
Clavulanic acid is a beta-lactam structurally related to penicillins. It inactivates some beta-lactamase enzymes thereby preventing inactivation of amoxicillin. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| B4-2492 | Tablet | SUGAM -625MG TAB 500 mg; 125 mg 2 X 7 | 28 RNW-PP-81464 SUGAM -625MG Amoxicillin Trihydrate and Clavulanate Potassium Amoxicillin Trihydrate USP Equivalent to Amoxicillin 500 mg Clavulanate Potassium USP Equivalent to Clavulanic Acid 125 mg Colloidal silicon dioxide USP Magnesium stearate USP Micro crystalline Cellulose USP Sodium starch glycolate USP Coating excipients Opadry White IH Iso propyl alcohol USP Methylene chloride USP B4-2492 Drugs Imported Products 2 X 7 Prescription Only Medicine (POM) 3/11/2019 JAWA INTERNATIONAL LIMITED, Plot 6, Abimbola Way, Isolo Industrial Estate 8036887062 spjawasil@gmail.com YELURI FORMULATIONS PVT LTD, SY. NO 296/7/6 , IDA BOLLARAM, SANGAREDDY DISTRICT-502 325, TELANGANA, INDIA, India | 30/11/2023 |
| B4-2493 | Tablet | Sugam Tablets 375mg TAB 250 mg; 125 mg 2 X 7 | Sugam Tablets 375Mg B4-2493 Sugam AMOXICILLIN + CLAVULANIC ACID ANTIBIOTIC AMOXICILLIN 250MG, CLAVULANIC ACID 125MG TABLETS 2 X 7 PRESCRIPTION ONLY MEDICINE TREATMENT OF BACTERIAL INFECTION CAUSED BY SUSCEPTIBLE MICROORGANISM JAWA INTERNATIONAL LTD NIGERIA YELURI FORMULATIONS PVT LTD INDIA 01/27/2022 01/26/2027 | 27/01/2022 |
| B4-2494 | Suspension | Sugam Powder For Oral Suspension SUSP 200 mg; 28.5 mg 1 X 70ML | Sugam Powder For Oral Suspension B4-2494 Sugam AMOXICILLIN +CLAVULANIC ACID ANTIBIOTIC AMOXICILLIN 200MG, CLAVULANIC ACID 28.5MG/5ML POWDER FOR ORAL SUSPENSION 1 X 70ML PRESCRIPTION ONLY MEDICINE TREATMENT OF BACTERIAL INFECTION CAUSED BY SUSCEPTIBLE MICROORGANISM JAWA INTERNATIONAL LTD NIGERIA YELURI FORMULATIONS PVT LTD INDIA 01/27/2022 01/26/2027 | 27/01/2022 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| J01CR02 | Amoxicillin and enzyme inhibitor | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01C Beta-lactam antibacterials, penicillins → J01CR Combinations of penicillins, incl. beta-lactamase inhibitors |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | B4-2492, B4-2493, B4-2494 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.